Opportunities to encourage adoption of a biomarker-enabled care pathway for Alzheimer's in primary care.

Identification of early-stage Alzheimer's disease (AD) remains a challenge due to limited specialist availability, diagnostic access, disease awareness, and cultural factors. Blood-based biomarkers (BBBM) could play a critical role in the identification and referral of patients suspected of AD to sp... View More